首页> 外文期刊>Toxicological sciences: An official journal of the Society of Toxicology >Evaluation of Serum Lipid, Thyroid, and Hepatic Clinical Chemistries in Association With Serum Perfluorooctanesulfonate (PFOS) in Cynomolgus Monkeys After Oral Dosing With Potassium PFOS
【24h】

Evaluation of Serum Lipid, Thyroid, and Hepatic Clinical Chemistries in Association With Serum Perfluorooctanesulfonate (PFOS) in Cynomolgus Monkeys After Oral Dosing With Potassium PFOS

机译:用PFOS在口服给药后与血清全氟辛磺酸盐(PFOS)与血清全氟辛磺酸盐(PFOS)相关的评价

获取原文
获取原文并翻译 | 示例
           

摘要

An oral dose study with perfluorooctanesulfonate (PFOS) was undertaken to identify potential associations between serum PFOS and changes in serum clinical chemistry parameters in purpose-bred young adult cynomolgus monkeys (Macaca fascicularis). In this study, control group (n = 6/sex) was sham-dosed with vehicle (0.5% Tween 20 and 5% ethanol in water), low-dose group (n = 6/sex) received 1 single K+PFOS dose (9 mg/kg), and high-dose group (n = 4-6/sex) received 3 separate K+ PFOS doses (11-17.2 mg/kg). Monkeys were given routine checkups and observed carefully for health problems on a daily basis. Scheduled blood samples were drawn from all monkeys prior to, during, and after K+PFOS administration for up to 1 year and they were analyzed for PFOS concentrations and clinical chemistry markers for coagulation, lipids, hepatic, renal, electrolytes, and thyroid-related hormones. No mortality occurred during the study. All the monkeys were healthy, gained weight, and were released back to the colony at the end of the study. The highest serum PFOS achieved was approximately 165 mu g/ml. When compared with time-matched controls, administration of K+PFOS to monkeys did not result in any toxicologically meaningful or clinically relevant changes in serum clinical measurements for coagulation, lipids, hepatic, renal, electrolytes, and thyroid-related hormones. A slight reduction in serum cholesterol (primarily the high-density lipoprotein fraction), although not toxicologically significant, was observed. The corresponding lower-bound fifth percentile benchmark concentrations (BMCL1sd) were 74 and 76 mu g/ml for male and female monkeys, respectively. Compared to the 2013-2014 geometric mean serum PFOS level of 4.99 ng/ml (0.00499 mu g/ml) in US general population reported by CDC NHANES, this represents 4 orders of magnitude for margin of exposure.
机译:对全氟辛酰磺酸盐(PFOS)进行了口服剂量研究,以识别血清PFOS之间的潜在关联,并在目的繁殖的年轻成人胞蔻猴(Macaca Fascicularis)中的血清临床化学参数的变化。在本研究中,对照组(N = 6 /性别)用载体(0.5%吐温20和5%乙醇在水中),低剂量组(n = 6 /性)接受1单k + pfos剂量(9mg / kg)和高剂量组(n = 4-6 /性)接受3个单独的k + pfos剂量(11-17.2 mg / kg)。猴子被给予常规检查,并每天仔细观察健康问题。在K + PFOS给药期间和之后的所有猴子中从所有猴子中抽出了预定的血液样品,最多1年,它们分析了PFOS浓度和临床化学标记,用于凝结,脂质,肝,肾,电解质和甲状腺相关相关的激素。研究期间没有死亡率。所有的猴子都是健康的,体重,并且在研究结束时被释放回殖民地。实现的最高血清PFOS约为165μg/ ml。与时间匹配的对照相比,K + PFOS给猴子的给药并未导致血清临床测量的任何毒理学有意义或临床相关变化,用于凝血,脂质,肾,肾,电解质和相关的荷尔蒙。观察到血清胆固醇(主要是高密度脂蛋白级分)虽然没有毒理学显着,但仍然没有毒理。相应的下限第五百分位数基准浓度(BMCL1SD)分别为男性和雌性猴子74和76μg/ ml。与2013-2014几何平均血清PFOS含量为4.99 ng / ml(0.00499μg/ ml),美国普通群体的美国一般人群,这代表了曝光边缘的4个级数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号